UOC
AKAO

UBS O'Connor’s Achaogen Inc AKAO Stock Holding History

UBS O'Connor’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,000
Closed -$866K – 355
2018
Q2 		$866K Buy
+100,000
New +$1.22M 0.02% 218
2017
Q3 		– Sell
-78,697
Closed -$1.71M – 492
2017
Q2 		$1.71M Buy
+78,697
New +$1.8M 0.03% 271

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

UBS O'Connor's AKAO Position: Q3 2018 in Review

UBS O'Connor sold out of Achaogen Inc (AKAO) in Q3 2018, closing a stake of 100,000 shares — an estimated $866K sold.

UBS O'Connor first reported a position in AKAO in Q2 2017 and held it in 2 quarters. The position peaked at $1.71M in Q2 2017. 92 funds tracked by Wall St. Rank hold AKAO as of Q3 2018.

  • UBS O'Connor reported no remaining Achaogen Inc position as of Q3 2018 after selling out during the quarter.
  • UBS O'Connor sold 100,000 Achaogen Inc shares in Q3 2018, an estimated $866K.
  • UBS O'Connor first reported a position in Achaogen Inc in Q2 2017 and held it in 2 quarters.
  • UBS O'Connor's Achaogen Inc position peaked at $1.71M in Q2 2017.
  • 92 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2018.

Based on UBS O'Connor's 13F filing for Q3 2018, filed 14 Nov 2018.